Nightingale’s biomarker analysis platform is routinely used in world-class epidemiological and genetic studies. There are over 450 publications that have applied our method.

Metabolic risk factors

Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population

Nightingale's blood biomarkers were used for prediction of severe pneumonia and COVID-19 hospitalisation in 105,146 plasma samples collected in the UK Biobank during 2007-2010.

Julkunen et al, ELife 2021

Read more